NCT03437161

A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation

Completed NA Last updated 17 February 2023

What this trial tests

NA trial testing Radiation Therapy (RT) in Breast Cancer in 40 participants. Completed in 15 February 2023.

Timeline

17 January 2017

Primary endpoint
26 September 2017

15 February 2023

Quick facts

Lead sponsor	NYU Langone Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	40
Start date	17 January 2017
Primary completion	26 September 2017
Estimated completion	15 February 2023

Drugs / interventions tested

• Radiation Therapy (RT)

Conditions studied

• Breast Cancer — all drugs for Breast Cancer →

Sponsor

NYU Langone Health — full company profile →

Who can join

18 and older, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This phase II trial studies how well deep inspiratory breath hold or prone breast radiation therapy works in reducing cardiac dose in patients with breast cancer or ductal carcinoma in situ. Deep inspiratory breath hold is a technique that involves a patient holding their breath during radiation to move the heart away from the breast to minimize radiation to the heart. Prone breast radiation therapy is a technique in which a patient receives treatment "face-down" to minimize the radiation to the rest of the body, including the heart and lungs. Comparing deep inspiratory breath hold to prone breast radiation therapy may help doctors improve radiation to the target while reducing radiation to healthy tissues surrounding the target.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.